Clinical Trial Update: An Efficacy and Safety Study of CNTO 148 Subcutaneous Injection Compared With Placebo in Patients With Active Rheumatoid Arthritis [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating the efficacy and safety of CNTO 148 subcutaneous injections versus placebo in active rheumatoid arthritis has completed, and results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• CNTO 148

Snippet

Sponsor: Centocor, Inc. | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED | Results posted: 2012-08-07